Edoxaban Tosylate
2 Inquiries
480449-71-6
Hyderabad
1kg
2022-01-01
Rabeprazole,Omeprazole,Silodosin,Levocetririzine
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceEdoxaban(DU-176) is an oral factor Xa (FXa) inhibitor in clinical development for stroke preventionIC50 Value:Target: factor XaEdoxaban is an oral factor Xa (FXa) inhibitor in clinical development for stroke prevention in patients with atrial fibrillation, an elderly population that frequently receives aspirin (ASA) and/or nonsteroidal anti-inflammatory drugs for concurrent illnesses[1].in vitro: Edoxaban PK was not affected by concomitant low-dose ASA or naproxen, but high-dose ASA incr
Edoxaban tosylate is an organosulfonate salt obtained by combining equimolar amounts of edoxaban and 4-toluenesulfonic acid. Used (in the form of its monohydrate) for the treatment of deep vein thrombosis and pulmonary embolism. It has a role as an anticoagulant, an EC 3.4.21.6 (coagulation factor Xa) inhibitor and a platelet aggregation inhibitor. It contains an edoxaban(1+).|Edoxaban Tosylate is the tosylate salt form of edoxaban, an orally active inhibitor of coagulation factor Xa (activated factor X) with anticoagulant activity. Edoxaban is administered as edoxaban tosylate. This agent has an elimination half-life of 9-11 hours and undergoes renal excretion.Basic Info-
Product Name:
Edoxaban tosylate
Other Name:Ethanediamide,N1-(5-chloro-2-pyridinyl)-N2-[(1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]-,4-methylbenzenesulfonate (1:1);Ethanediamide,N-(5-chloro-2-pyridinyl)-N′-[(1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]-,mono(4-methylbenzenesulfonate);Edoxaban tosylate;DU 176b;Savaysa;Lixiana;Roteas;912273-65-5
CAS No.:480449-71-6
Molecular Formula:C24H30ClN7O4S.C7H8O3S
InChIKeys:InChIKey=ZLFZITWZOYXXAW-QXXZOGQOSA-N
Molecular Weight:720.25912
Exact Mass:719.196289
EC Number:1592732-453-0
UNII:32W99UE810
DSSTox ID:DTXSID10197399
NCI Thesaurus Code:C96542
ATC Code:B01|B01AF03
Categories:
Characteristics-
PSA:
227.62000
XLogP3:4.40480
Hazard IdentificationClassification of the substance or mixture
Acute toxicity - Category 4, Oral
GHS label elements, including precautionary statements
Pictogram(s) 
Signal word Warning
Hazard statement(s) H302 Harmful if swallowed
Precautionary statement(s) Prevention P264 Wash ... thoroughly after handling.
P270 Do not eat, drink or smoke when using this product.
Response P301+P317 IF SWALLOWED: Get medical help.
P330 Rinse mouth.
Storage none
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Rabeprazole,Omeprazole,Silodosin,Levocetririzine
-
Location:
Bhanu Enclave, No 302, above Hero Showroom, Sundar Nagar, Erragadda, Hyderabad, Telangana 500038
-
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A
-
Average lead Time:
365
-
Total Annual Revenue:
Above $100 million
-
Total Employees:
Above 1000
-
Year of Establishment:
2002
-
-
Inquiry History2 Inquiries
Country Product Purchase Quantity Date Posted 
South Korea
Edoxaban Tosylate
500 KG Sep 3, 2026 
India
EDOXABAN TOSYLATE
10 G Jul 29, 2024 Post an enquiry for this product